Desitin Arzneimittel GmbH

Pozen Shares On The Rebound Since European Migraine Licensing Deal
Seeking Alpha
Mon, 05/14/12 - 11:39 am
Pozen
Europe
migraines
Desitin Arzneimittel GmbH
MT-400